ID

22464

Descrizione

Study ID: 100273 Clinical Study ID: HS2100273 Study Title: A Randomized, Double-Blind, Placebo-Controlled, Multicenter 60-Day Study Comparing the Efficacy of Valtrex 1 Gram Once Daily vs. Placebo Once Daily in Reducing Viral Shedding in Immunocompetent Subjects with Recurrent HSV-2 Genital Herpes Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Completed Generic Name: valaciclovir Trade Name: ZELITREX,Valtrex,RAPIVIR,Novirus Study Indication: Herpes Genitalis Visit description: Investigational Product

Keywords

versioni (1)
  1. 2017-06-05 2017-06-05 -
Caricato su

5 juni 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Efficacy of Valtrexin in Subjects with Recurrent HSV-2 Genital Herpes Study Investigational Product

Inglese

Efficacy of Valtrexin in Subjects with Recurrent HSV-2 Genital Herpes Study Investigational Product

1 moduli  
Investigational Product
Descrizione

Investigational Product

Alias
UMLS CUI-1
C0304229
Investigational Product
Descrizione

Investigational Product

Tipo di dati

text

Alias
UMLS CUI [1]
C0304229
Start Date
Descrizione

Start Date

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C0304229
Stop Date
Descrizione

Stop Date

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0806020
UMLS CUI [1,2]
C0304229
Investigational Product Compliance
Descrizione

Investigational Product Compliance

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C1321605
Investigational Product
Descrizione

Investigational Product

Tipo di dati

text

Alias
UMLS CUI [1]
C0304229
Date Investigational Product Dispensed
Descrizione

Date Investigational Product Dispensed

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0947323
UMLS CUI [1,3]
C0304229
Number of Tablets/Caplets Dispensed
Descrizione

Number of Tablets Dispensed

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0805077
UMLS CUI [1,2]
C0750480
UMLS CUI [1,3]
C0304229
Date Investigational Product Returned
Descrizione

Date Investigational Product Returned

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0332156
UMLS CUI [1,3]
C0304229
Number of Tablets/Caplets Returned
Descrizione

Number of Tablets Returned

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C2699071
UMLS CUI [1,2]
C0750480
UMLS CUI [1,3]
C0304229
Investigational Product Discontinuation
Descrizione

Investigational Product Discontinuation

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C0457454
Was the investigational product stopped permanently before the end of the scheduled treatment period?
Descrizione

investigational product stopped

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0457454
If Yes, check the primary reason the investigational product was stopped:
Descrizione

reason the investigational product was stopped

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C0304229
UMLS CUI [1,3]
C0457454
If other reason, please specify
Descrizione

reason the investigational product was stopped

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C0304229
UMLS CUI [1,3]
C0457454
Ritorna all'inizio della pagina

Similar models

Efficacy of Valtrexin in Subjects with Recurrent HSV-2 Genital Herpes Study Investigational Product

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Investigational Product
C0304229 (UMLS CUI-1)
Investigational Product
Item
Investigational Product
text
C0304229 (UMLS CUI [1])
Start Date
Item
Start Date
date
C0808070 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Stop Date
Item
Stop Date
date
C0806020 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Item Group
Investigational Product Compliance
C0304229 (UMLS CUI-1)
C1321605 (UMLS CUI-2)
Investigational Product
Item
Investigational Product
text
C0304229 (UMLS CUI [1])
Date Investigational Product Dispensed
Item
Date Investigational Product Dispensed
date
C0011008 (UMLS CUI [1,1])
C0947323 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
Number of Tablets Dispensed
Item
Number of Tablets/Caplets Dispensed
integer
C0805077 (UMLS CUI [1,1])
C0750480 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
Date Investigational Product Returned
Item
Date Investigational Product Returned
date
C0011008 (UMLS CUI [1,1])
C0332156 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
Number of Tablets Returned
Item
Number of Tablets/Caplets Returned
integer
C2699071 (UMLS CUI [1,1])
C0750480 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
Item Group
Investigational Product Discontinuation
C0304229 (UMLS CUI-1)
C0457454 (UMLS CUI-2)
Item
Was the investigational product stopped permanently before the end of the scheduled treatment period?
text
C0304229 (UMLS CUI [1,1])
C0457454 (UMLS CUI [1,2])
investigational product stopped
Code List
Was the investigational product stopped permanently before the end of the scheduled treatment period?
CL Item
Yes (Y)
CL Item
No (N)
Item
If Yes, check the primary reason the investigational product was stopped:
integer
C0392360 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,3])
reason the investigational product was stopped
Code List
If Yes, check the primary reason the investigational product was stopped:
CL Item
Adverse event , Record details on the Non-Serious Adverse Events or Serious Adverse Event pages as appropriate.  (1)
CL Item
Lost to follow-up  (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study  (4)
CL Item
Other (5)
reason the investigational product was stopped
Item
If other reason, please specify
text
C0392360 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,3])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial